390
Participants
Start Date
June 1, 2025
Primary Completion Date
January 1, 2027
Study Completion Date
December 31, 2027
TRT
"Comprehensive metastasis-directed radiotherapy:~* Targets: Primary prostate tumor + all metastatic lesions (≤10 sites confirmed by PSMA PET)~* Concurrent therapy: Standard systemic treatment (ADT + novel hormonal agents)"
NTRT
"Standard primary radiotherapy:~* Targets: Prostate primary tumor only~* Concurrent therapy: Same systemic treatment as experimental arm"
RECRUITING
Peking University First Hospital, Beijing
NOT_YET_RECRUITING
Peking University Cancer Hospital, Beijing
NOT_YET_RECRUITING
Peking University Third Hospital, Beijing
Peking University First Hospital
OTHER